Hazelnut consumption decreases the susceptibility of LDL to oxidation, plasma oxidized LDL level and increases the ratio of large/small LDL in normolipidemic healthy subjects

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 1, 2010, Pages 28-35

  Yücesan, Fulya Balaban ^a   Örem, Asim ^a   Kural, Birgül Vanizor ^a   Örem, Cihan ^a   Turan, Ibrahim ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

tocopherol; Atherogenic tendency of LDL; Hazelnut consumption; Lipids; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A; APOLIPOPROTEIN B; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; ENDOTHELIN 1; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; NATURAL PRODUCT; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANTIATHEROGENIC ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; GENOTYPE; HAZELNUT; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; NUTRITIONAL VALUE;

ADULT; ALPHA-TOCOPHEROL; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, LDL; CORYLUS; ENDOTHELIN-1; ENERGY INTAKE; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; REFERENCE VALUES; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 76649111343     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Coates AM, Howe PRC. Edible nuts and metabolic health. Curr Opin Lipidol 2007; 18: 25-30.
2. Kelly JH, Sabate J. Nuts and coronary heart disease: an epidemiological perspective. Br J Nutr 2006; 68 Suppl: S61-S67.
3. FDA. Qualified Health Claims: Letter of Enforcement Discretion-Nuts and Coronary Heart Disease; FDA, Docket 02P-0505: Washington, DC. 2003. Available at URL : http://www.fda.gov/Food/LabelingNutrition/ LabelClaims/ QualifiedHealthClaims/ucm072926.htm
4. Durak I, Köksal I, Kaçmaz M, Büyükkoçak S, Çimen BMY, Öztürk HS. Hazelnut supplementation enhances plasma antioxidant potential and lowers plasma cholesterol levels. Clinica Chimica Acta 1999; 284: 113-5.
5. Mercanligil SM, Arslan P, Alasalvar C, Okut E, Akgül E, Pinar A, et al. Effects of hazelnut-enriched diet on plasma cholesterol and lipoprotein profiles in hypercholesterolemic adult men. European J Clin Nutr 2006; 61: 1-9.
6. Alasalvar C, Amaral JS, Shahidi F. Functional lipid characteristics of Turkish Tombul hazelnut (Corylus avellana L.). J Agric Food Chem 2006; 54: 10177-83.
7. Sabaté J. Nut consumption and body weight. Am J Clin Nutr 2003; suppl 78: 647S-650S.
8. Heyden S. Polyunsaturated and monounsaturated fatty acids in the diet to prevent coronary heart disease via cholesterol reduction. Ann Nutr Metab 1994; 38: 117-22.
9. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherogenesis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998; 141: 1-15.
10. Reaven PD, Witzum JL. Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Annu Rev Nutr 1996; 16: 51-71.
11. Moreno JA, Perez-Jimanez F, Marin C, Gomez P, Perez-Martinez P, Moreno R, et al. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr 2004; 134: 2517-22.
12. Ruiz C, Alergria A, Barberá R, Farré R, Lagarga MN. Determination of lipid hydroperoxides by an NADPH/NADP coupled enzyme reaction system; Evaluation of a method. Eur J Clin Chem Clin Biochem 1997; 35: 893-8.
13. Erel Ö. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004; 37: 112-9.
14. Sclavons MM, Cordonnier CM, Mailleux PM, Heler FR, Desager J, Harvengt CM. Fast separation of the three main plasma lipoprotein classes by ultracentrifugation using vertical rotor and multiple discontinuous density gradient. Clin Chim Acta 1985; 153: 125-35.
15. Pulh H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 1995; 233: 425-40.
16. Pussinen PJ, Linder H, Glatter O. Lipoprotein associated α-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochimica et Biophysica Acta 2006; 1485: 129-44.
17. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low-density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104.
18. Vega GL, Ma PTS, Cater NB. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome. Am J Cardiol 2003; 91: 956-60.
19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-8.
20. Galle J, Hansen-Hagge T, Wanner C, Seibold S. Impact of oxidized low- density lipoprotein on vascular cells. Atherosclerosis 2006; 185: 219-26.
21. Ros E, Núñez I, Pérez-Heras A, Serra M, Gilabert R, Casals E, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects. Circulation 2004; 109: 1609-14.
22. Ros E, Mataix J. Fatty acid composition of nuts-implications for cardiovascular health. Br J Nutr 2006; 96 Suppl: S29-S35.
23. Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarty K, Fishell V et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 1999; 70: 1009-15.
24. Lapointe A, Couillard C, Lemieux S. Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem 2006; 17: 645-58.
25. Kornsteiner M, Wagner KH, Elmadfa I. Tocopherols and total phenolics in ten different nut types. Food Chem 2006; 98: 381-7.
26. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 2000; 87: 349-54.
27. Munteanu A, Zingg JM, Azzi A. Anti-atherosclerotic effects of vitamin E-myth or reality. J Cell Mol Med 2004; 8: 59-76.
28. Galssetti P, Pontello A. Dietary effects on oxidation of low-density lipoprotein and atherogenesis. Curr Atherosc Reports 2006; 8: 523-9.
29. Schwenke DC, Carew TE. Initiation of atherosclerotic lesion in cholesterol-fed rabbits: II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 1989; 9: 908-18.
30. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748-52.
31. Metso S, Loimaala A, Mercuri MF, Nenonen A, Vuori I, Oja P, et al. Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness in a random sample of middle-aged men. J Biomed Sci 2004; 11: 356-61.
32. Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J. Oxidized lowdensity lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 2004; 256: 413-20.
33. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2243-7.
34. Meisenger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middleaged men from the general population. Circulation 2005; 112: 651-7.
35. Koçyiǧit A, Koylu AA, Keleş H. Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Met Cardiovasc Dis 2006; 16: 202-9.
36. Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr 2006; 96 (suppl 2): S68-S78.
37. Almario RU, Vonghavaravat V, Wong R, Karakas S-K. Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr 2001; 74: 72-9.
38. Ross R. Mechanisms of disease-athersoclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
39. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001; 73: 673-86.
40. St-Onge, Marie-Pierre. Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am J Clin Nutr 2005; 81: 7-15.
41. Rajaram, J and Sabaté, J. Nuts, body weight and insulin resistance. Br J Nutr 2006; 96, Suppl. 2: S79-S86.
42. Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 2002; 76: 1000-6.
43. Garg A, Bonanome A, Grundy SM, Zhang ZJ, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988; 319: 829-34.